DSM-5 and ICD-10: Implications for the Assessment/Evaluation and Treatment for Substance-Related and Co-Occurring Disorders | Supported by AdCare


Event Details


This session will focus on the DSM-5 changes related to the previous DSM-IV-TR, as well as the upcoming use of the ICD-10-CM on Oct. 1.